| /en/general-shareholders-meeting | | General Shareholders’ Meeting |
| /en/general-shareholders-meeting | Text duplicate | General Shareholders’ Meeting |
| /en/contact | | Contact us |
| /en/international-headquarters | | International Headquarters |
| /en/notification-of-adverse-re... | | Adverse reactions - Pharmacovigilance |
| http://grifols.ethicspoint.com/ | New window External Subdomain | Grifols Ethics Line |
| /en/c/portal/update_language?p... | | Español |
| /en/c/portal/update_language?p... | | Deutsch |
| /en/c/portal/update_language?p... | | 中文 |
| /en/grifols-d3/home | | IMG-ALT 'Grifols.com' logo A-TITLE Go to Grifols.com |
| /en/company | | Trivial anchor text Read more |
| /en/board-directors | | Board of Directors |
| /en/management-team | | Management Team |
| /en/what-we-do | | What We Do |
| /en/biopharma | | Biopharma |
| /en/diagnostic | | Diagnostic |
| /en/bio-supplies | | Bio Supplies |
| /en/healthcare-solutions-for-h... | | Healthcare Solutions for Hospitals |
| /en/mission-and-values | | Mission, vision and values |
| /en/ethics-and-compliance | | Ethics and Compliance |
| /en/our-history | | Our History |
| /en/grifols-museum | | Grifols Museum |
| /en/grifols-museum-la-casa-whe... | | La Casa: Where It All Began |
| /en/grifols-museum-the-plant-p... | | The Plant: People Helping People |
| /en/grifols-museum-the-world-f... | | The World: From Family Business to Global Company |
| /en/grifology-connecting-innov... | | Grifology |
| /en/the-cabinet-century-of-inn... | | The Cabinet |
| /en/grifols-engineering | | Grifols Engineering |
| /en/mission-and-values | | Every action we take is motivated by our mission to improve people's lives. |
| /en/our-history | | Our unique and remarkable history combines scientific expertise with a desire to serve patients and society. |
| /en/what-we-do | | We develop, produce and market innovative medicines, solutions and services in more than 110 countries. |
| /en/innovation | Text duplicate | Trivial anchor text Read more |
| /en/plasma-powerhouse | | Plasma Powerhouse |
| /en/beyond-plasma | | Beyond Plasma |
| /en/key-therapeutic-areas | | Key Therapeutic Areas |
| /en/immunology | | Immunology |
| /en/hepatology-and-intensive-care | | Hepatology and Intensive Care |
| /en/pulmonology | | Pulmonology |
| /en/hematology | | Hematology |
| /en/neurology | | Neurology |
| /en/infectious-diseases | | Infectious Diseases |
| /en/further-therapeutic-opport... | | Further Therapeutic Opportunities |
| /en/chronos-pd | | CHRONOS-PD: Plasma Science in Parkinson’s Research |
| /en/extending-our-innovative-r... | | Extending Our Innovative Reach |
| /en/team-up-with-grifols-innov... | | Team Up with Grifols Innovation and New Technologies |
| /en/scientific-awards-and-prog... | | Scientific Awards and Programs |
| /en/connecting-knowledge-our-r... | | Connecting Knowledge - Our R&D Network |
| /en/plasma-powerhouse | | We apply our growing knowledge of plasma to change healthcare. |
| /en/key-therapeutic-areas | | Our treatments are enhancing people’s well-being and quality of life. |
| /en/connecting-knowledge-our-r... | | We’re drawing on a broad scientific base to continue innovating. |
| /en/sustainability | Text duplicate | Trivial anchor text Read more |
| /en/supporting-patients | | Supporting Patients |
| /en/supporting-donors | | Supporting Donors |
| /en/our-people | | Our People |
| /en/impact-on-society | | Social Action |
| /en/the-environment | | Environmental Responsibility |
| /en/ethical-leadership | | Ethical Leadership |
| /en/sustainability-reports | | Sustainability Reports & Corporate Policies |
| /documents/3625622/8322595/IAR... | New window | 2025 Integrated and Sustainability Annual Report |
| /en/innovation | | Innovating with purpose to drive positive impact |
| https://products.grifols.com/ | New window External Subdomain | Products |
| /en/investors | Text duplicate | Trivial anchor text Read more |
| /en/stock-and-capital | | Stock and share capital |
| /en/dividends | | Dividends |
| /en/major-holders-and-treasury... | | Major Holders and Treasury Stock |
| /en/agreements-between-shareho... | | Agreements between Shareholders |
| /en/analyst-coverage | | Analyst Coverage |
| /en/financial-results | | Financial Results |
| /en/annual-accounts | | Annual Accounts |
| /en/fixed-income-and-credit-ra... | | Fixed Income and Credit Ratings |
| /en/average-period-of-payment-... | | Average Period of Payment to Suppliers |
| /en/key-figures | | Key Figures |
| /en/press-releases | | Press Releases |
| /en/presentations-and-events | | Presentations and Events |
| https://www.grifols.com/en/agenda | | Agenda |
| https://www.cnmv.es/portal/con... | New window External Subdomain | CNMV |
| https://www.sec.gov/cgi-bin/br... | New window External Subdomain | SEC |
| /en/other-relevant-information | | Other Relevant Information |
| /en/inside-information | | Inside Information |
| /en/relevant-events | | Significant events until 8 February 2020 |
| /en/corporate-stewardship-reports | | Corporate Stewardship Reports |
| /en/board-of-directors | Text duplicate | Board of Directors |
| /en/general-shareholders-meeting | Text duplicate | General Shareholders’ Meeting |
| /en/annual-corporate-governanc... | | Annual Corporate Governance Report |
| /en/directors-remuneration-report | | Directors' Remuneration Report |
| /en/articles-of-association | | Articles of Association |
| /en/corporate-policies | | Corporate Policies |
| /en/mergers | | Mergers |
| /en/biotest-voluntary-takeover... | | Biotest: Voluntary Takeover Offer | Freiwilliges Übernahmeangebot (2021) |
| /en/biotest-acquisition-offer | | Biotest: Acquisition offer (delisting) / freiwilliges Erwerbsangebot (Delisting) (2025) |
| /documents/3625622/8482059/pr-... | New window | Presentation First-Quarter 2026 Results |
| /documents/3625622/8322595/IAR... | New window Text duplicate | 2025 Integrated and Sustainability Annual Report |
| /en/careers | | Explore Opportunities |
| /en/why-grifols | | Why Grifols |
| /en/culture | | People & Culture |
| https://www.grifols.com/en/teams | | Our teams |
| /en/training-and-development | | Training and Development |
| /en/hiring-journey | | Hiring Journey |
| /en/early-careers | | Early Careers |
| https://www.grifols.com/en/media | Text duplicate | Trivial anchor text Read more |
| /en/newsroom | | Newsroom |
| https://www.grifols.com/en/events | | Events |
| /en/q1-2026-financial-results | | Q1 2026 Financial Results |
| /en/full-year-2025-financial-r... | | Full-Year 2025 Financial Results |
| /en/media-contacts | | Media Contacts |
| /en/media-center | | Media Center |
| /en/suppliers | | More details |
| /en/join-grifols-supplier-network | | Join Grifols Supplier Network |
| /en/c/portal/update_language?p... | Text duplicate | Español |
| /en/c/portal/update_language?p... | Text duplicate | Deutsch |
| /en/c/portal/update_language?p... | Text duplicate | 中文 |
| /en/company | | Company |
| /en/board-directors | Text duplicate | Board of Directors |
| /en/management-team | Text duplicate | Management Team |
| /en/what-we-do | Text duplicate | What We Do |
| /en/biopharma | Text duplicate | Biopharma |
| /en/diagnostic | Text duplicate | Diagnostic |
| /en/bio-supplies | Text duplicate | Bio Supplies |
| /en/healthcare-solutions-for-h... | Text duplicate | Healthcare Solutions for Hospitals |
| /en/mission-and-values | Text duplicate | Mission, vision and values |
| /en/ethics-and-compliance | Text duplicate | Ethics and Compliance |
| /en/our-history | Text duplicate | Our History |
| /en/grifols-museum | Text duplicate | Grifols Museum |
| /en/grifols-museum-la-casa-whe... | Text duplicate | La Casa: Where It All Began |
| /en/grifols-museum-the-plant-p... | Text duplicate | The Plant: People Helping People |
| /en/grifols-museum-the-world-f... | Text duplicate | The World: From Family Business to Global Company |
| /en/grifology-connecting-innov... | Text duplicate | Grifology |
| /en/the-cabinet-century-of-inn... | Text duplicate | The Cabinet |
| /en/grifols-engineering | Text duplicate | Grifols Engineering |
| /en/innovation | | Innovation |
| /en/plasma-powerhouse | Text duplicate | Plasma Powerhouse |
| /en/beyond-plasma | Text duplicate | Beyond Plasma |
| /en/key-therapeutic-areas | Text duplicate | Key Therapeutic Areas |
| /en/immunology | Text duplicate | Immunology |
| /en/hepatology-and-intensive-care | Text duplicate | Hepatology and Intensive Care |
| /en/pulmonology | Text duplicate | Pulmonology |
| /en/hematology | Text duplicate | Hematology |
| /en/neurology | Text duplicate | Neurology |
| /en/infectious-diseases | Text duplicate | Infectious Diseases |
| /en/further-therapeutic-opport... | Text duplicate | Further Therapeutic Opportunities |
| /en/chronos-pd | Text duplicate | CHRONOS-PD: Plasma Science in Parkinson’s Research |
| /en/extending-our-innovative-r... | Text duplicate | Extending Our Innovative Reach |
| /en/team-up-with-grifols-innov... | Text duplicate | Team Up with Grifols Innovation and New Technologies |
| /en/scientific-awards-and-prog... | Text duplicate | Scientific Awards and Programs |
| /en/connecting-knowledge-our-r... | Text duplicate | Connecting Knowledge - Our R&D Network |
| /en/sustainability | | Sustainability |
| /en/supporting-patients | Text duplicate | Supporting Patients |
| /en/supporting-donors | Text duplicate | Supporting Donors |
| /en/our-people | Text duplicate | Our People |
| /en/impact-on-society | Text duplicate | Social Action |
| /en/the-environment | Text duplicate | Environmental Responsibility |
| /en/ethical-leadership | Text duplicate | Ethical Leadership |
| /en/sustainability-reports | Text duplicate | Sustainability Reports & Corporate Policies |
| https://products.grifols.com/ | New window External Subdomain Text duplicate | Products |
| /en/investors | | Investors |
| /en/stock-and-capital | Text duplicate | Stock and share capital |
| /en/dividends | Text duplicate | Dividends |
| /en/major-holders-and-treasury... | Text duplicate | Major Holders and Treasury Stock |
| /en/agreements-between-shareho... | Text duplicate | Agreements between Shareholders |
| /en/analyst-coverage | Text duplicate | Analyst Coverage |
| /en/financial-results | Text duplicate | Financial Results |
| /en/annual-accounts | Text duplicate | Annual Accounts |
| /en/fixed-income-and-credit-ra... | Text duplicate | Fixed Income and Credit Ratings |
| /en/average-period-of-payment-... | Text duplicate | Average Period of Payment to Suppliers |
| /en/key-figures | Text duplicate | Key Figures |
| /en/press-releases | Text duplicate | Press Releases |
| /en/presentations-and-events | Text duplicate | Presentations and Events |
| https://www.grifols.com/en/agenda | Text duplicate | Agenda |
| https://www.cnmv.es/portal/con... | New window External Subdomain Text duplicate | CNMV |
| https://www.sec.gov/cgi-bin/br... | New window External Subdomain Text duplicate | SEC |
| /en/other-relevant-information | Text duplicate | Other Relevant Information |
| /en/inside-information | Text duplicate | Inside Information |
| /en/relevant-events | Text duplicate | Significant events until 8 February 2020 |
| /en/corporate-stewardship-reports | Text duplicate | Corporate Stewardship Reports |
| /en/board-of-directors | Text duplicate | Board of Directors |
| /en/general-shareholders-meeting | Text duplicate | General Shareholders’ Meeting |
| /en/annual-corporate-governanc... | Text duplicate | Annual Corporate Governance Report |
| /en/directors-remuneration-report | Text duplicate | Directors' Remuneration Report |
| /en/articles-of-association | Text duplicate | Articles of Association |
| /en/corporate-policies | Text duplicate | Corporate Policies |
| /en/mergers | Text duplicate | Mergers |
| /en/biotest-voluntary-takeover... | Text duplicate | Biotest: Voluntary Takeover Offer | Freiwilliges Übernahmeangebot (2021) |
| /en/biotest-acquisition-offer | Text duplicate | Biotest: Acquisition offer (delisting) / freiwilliges Erwerbsangebot (Delisting) (2025) |
| /en/careers | | Careers |
| /en/why-grifols | Text duplicate | Why Grifols |
| /en/culture | Text duplicate | People & Culture |
| https://www.grifols.com/en/teams | Text duplicate | Our teams |
| /en/training-and-development | Text duplicate | Training and Development |
| /en/hiring-journey | Text duplicate | Hiring Journey |
| /en/early-careers | Text duplicate | Early Careers |
| https://www.grifols.com/en/media | | Media |
| /en/newsroom | Text duplicate | Newsroom |
| https://www.grifols.com/en/events | Text duplicate | Events |
| /en/q1-2026-financial-results | Text duplicate | Q1 2026 Financial Results |
| /en/full-year-2025-financial-r... | Text duplicate | Full-Year 2025 Financial Results |
| /en/media-contacts | Text duplicate | Media Contacts |
| /en/media-center | Text duplicate | Media Center |
| /en/suppliers | | Suppliers |
| /en/join-grifols-supplier-network | Text duplicate | Join Grifols Supplier Network |
| https://www.linkedin.com/compa... | New window External Subdomain | No Text |
| https://www.youtube.com/channe... | New window External Subdomain | No Text |
| https://www.instagram.com/grif... | New window External Subdomain | No Text |
| /en/what-we-do | Text duplicate | What We Do |
| /en/view-news/-/news/grifols-l... | | Read Release |
| /en/view-news/-/news/grifols-e... | Text duplicate | Read Release |
| /en/view-news/-/news/grifols-b... | Text duplicate | Read Release |
| /en/newsroom | | Show more news |
| /en/our-history | Text duplicate | Trivial anchor text Read more |
| /en/sustainability | Text duplicate | Trivial anchor text Read more |
| /en/innovation | Text duplicate | Trivial anchor text Read more |
| /en/our-history | Text duplicate | Trivial anchor text Read more |
| /en/company | Text duplicate | Trivial anchor text Read more |
| /en/careers | Text duplicate | Trivial anchor text Read more |
| /en/biopharma | Text duplicate | Trivial anchor text Read more |
| /en/grifols-d3/home | Text duplicate | IMG-ALT 'Grifols.com' logo A-TITLE Go to Grifols.com |
| /en/company | Text duplicate | Company |
| /en/sustainability | Text duplicate | Sustainability |
| /en/innovation | Text duplicate | Innovation |
| https://products.grifols.com/e... | External Subdomain Text duplicate | Products |
| /en/investors | Text duplicate | Investors |
| /en/careers | Text duplicate | Careers |
| https://www.grifols.com/en/media | Text duplicate | Media |
| https://www.grifolsplasma.com/ | External Subdomain | Grifols Plasma |
| https://www.diagnostic.grifols... | External Subdomain | Grifols Diagnostics Solutions |
| https://www.grifolsscientifica... | External Subdomain | Grifols Scientific Awards |
| https://www.grifolsengineering... | External Subdomain Text duplicate | Grifols Engineering |
| https://www.grifolsegyptplasma... | External Subdomain | Grifols Egypt for Plasma Derivatives |
| https://www.fundaciogrifols.org/ | External Subdomain | Victor Grifols i Lucas Foundation |
| http://www.fundacionprobitas.org/ | External Subdomain | Probitas Foundation |
| https://www.joseantoniogrifols... | External Subdomain | J.A. Grifols Foundation |
| /en/privacy-notices | | Privacy Notices |
| /en/cookies-policy | | Cookies Policy |
| /en/terms-of-use | | Terms of Use |
| https://secure.ethicspoint.eu/... | External Subdomain Text duplicate | Grifols Ethics Line |
| /en/contact | | Contact |
| /en/glossary | | Glossary |
| https://www.linkedin.com/compa... | New window External Subdomain | No Text |
| https://www.youtube.com/channe... | New window External Subdomain | No Text |
| https://www.instagram.com/grif... | New window External Subdomain | No Text |
(Nice to have)